Related Experiment Video
Updated: Oct 13, 2025

Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
Published on: December 22, 2023
The Arrhythmic Phenotype in Cardiomyopathy
Marco Merlo1, Giulia Grilli1, Chiara Cappelletto1
1Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI), University of Trieste, Italy.
Insights
Sudden cardiac death (SCD) remains a major concern in cardiomyopathies. This review guides clinicians on identifying high-risk patients for SCD prevention, focusing on arrhythmic risk stratification.
Area of Science:
- Cardiology
- Genetics
- Internal Medicine
Background:
- Cardiomyopathies encompass a range of heart muscle diseases with a wide phenotypic spectrum.
- Sudden cardiac death (SCD) is a devastating complication, necessitating effective risk stratification strategies.
Purpose of the Study:
- To review current evidence on arrhythmic expression and risk stratification across different cardiomyopathy phenotypes.
- To provide practical guidance for clinicians in identifying patients at high risk of SCD.
Main Methods:
- Comprehensive literature review of studies on cardiomyopathies, SCD, and risk stratification.
- Analysis of arrhythmic manifestations and predictive markers in various cardiomyopathy types.
Main Results:
- Implantable cardioverter-defibrillators have shifted focus from 'how' to 'whom' to protect from SCD.
- Uncertainty persists regarding the most reliable methods for identifying highest-risk patients.
- Evidence synthesis aims to clarify risk stratification approaches for diverse cardiomyopathies.
Conclusions:
- Effective risk stratification is crucial for optimizing SCD prevention in cardiomyopathy patients.
- A systematic approach to evaluating arrhythmic risk is needed for improved clinical management.
- This review offers practical insights to aid clinicians in daily practice.
Abstract:
In the wide phenotypic spectrum of cardiomyopathies, sudden cardiac death (SCD) has always been the most visible and devastating disease complication. The introduction of implantable cardioverter-defibrillators for SCD prevention by the late 1980s has moved the question from how to whom we should protect from SCD, leaving clinicians with a measure of uncertainty regarding the most reliable option to guide identification of the highest-risk patients. In this review, we will go through all the available evidence in the field of arrhythmic expression and arrhythmic risk stratification in the different phenotypes of cardiomyopathies to provide practical suggestions in daily clinical management.
More Related Videos
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Mechanism of Cardiac Arrhythmias
Cardiomyopathy IV: Restrictive Cardiomyopathy
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Electrophysiology of Normal Cardiac Rhythm

